Editorial
doi: 10.1186/gb-2009-10-3-103.
Epub 2009 Mar 30.
Too big to succeed?
- PMID: 19344496
- PMCID: PMC2690990
- DOI: 10.1186/gb-2009-10-3-103
Item in Clipboard
Editorial
Too big to succeed?
Genome Biol.
2009.
Abstract
Bigger is not necessarily more beautiful when big pharma mergers are at issue.
Similar articles
-
US drug manufacturers set up joint testing group.BMJ. 2012 Sep 21;345:e6394. doi: 10.1136/bmj.e6394. BMJ. 2012. PMID: 23002149 No abstract available.
-
Spat over IMI funding and intellectual property.Nat Biotechnol. 2011 Jun 7;29(6):473. doi: 10.1038/nbt0611-473a. Nat Biotechnol. 2011. PMID: 21654659 No abstract available.
-
[Bayer Schering Pharma--support stipend for 2008].Rofo. 2008 Jul;180(7):685. doi: 10.1055/s-2008-1081423. Rofo. 2008. PMID: 18561073 German. No abstract available.
-
[Open innovation and licensing in the pharmaceutical industry].Nihon Yakurigaku Zasshi. 2013 Jul;142(1):28-31. doi: 10.1254/fpj.142.28. Nihon Yakurigaku Zasshi. 2013. PMID: 23842225 Review. Japanese. No abstract available.
-
Drug discovery: new models for industry-academic partnerships.Drug Discov Today. 2009 Jan;14(1-2):95-101. doi: 10.1016/j.drudis.2008.10.003. Epub 2008 Nov 21. Drug Discov Today. 2009. PMID: 18992364 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
